Nir Sassi
Fortune : 47 094 $ au 31/05/2026
Fortune : 47 094 $ au 31/05/2026
Nir Sassi worked as Senior Manager at PricewaterhouseCoopers (Israel) from 2002 to 2010.
Served as Chief Financial Officer at Intec Pharma Ltd. from 2016 to 2021.
Served as Chief Financial Officer at Indaptus Therapeutics, Inc. from 2021 to 2023.
Completed undergraduate studies at Ben-Gurion University of the Negev.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/12/2025 | 26 758 ( 0,02 % ) | 47 094 $ | 31/05/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| INDAPTUS THERAPEUTICS, INC. | Directeur Financier/CFO | 01/04/2026 |
PricewaterhouseCoopers (Israel)
PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/2010 |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat neurodegenerative diseases | Directeur Financier/CFO | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
PricewaterhouseCoopers (Israel)
PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat neurodegenerative diseases | Health Technology |
Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national